Mosaic ImmunoEngineering (OTCMKTS:CPMV) Stock Price Down 5.2% – Here’s Why

Shares of Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) fell 5.2% on Thursday . The company traded as low as $0.6388 and last traded at $0.6388. Approximately 224 shares traded hands during trading, an increase of 1,782% from the average session volume of 12 shares. The stock had previously closed at $0.6740.

Mosaic ImmunoEngineering Price Performance

The firm has a market cap of $4.62 million, a PE ratio of -7.10 and a beta of -0.92. The company’s 50 day moving average price is $0.66 and its two-hundred day moving average price is $0.60.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($0.02) EPS for the quarter.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.